Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln
Aug 26 (Reuters) - Cereno Scientific ABCRNOSb.ST : * Q2 ADJUSTED EPS SEK -0.1 * Q2 2026 NET SALES WERE SEK 0 * Q2 2026 RESULT AFTER FINANCIAL ITEMS WAS SEK -30,528,669 Source text:ID:nMFN3q0MsV Further company coverage:CRNOSb.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Cereno Scientific AB
See all newsBrief: Cereno Scientific Expects Up To 15 Activated Sites By 2026 In Epimode Trial
Brief: Cereno Scientific Reports Positive Results From Study
Brief: Cereno Scientific Q2 Net Sales Sek 0
Sweden's Cereno Scientific Q2 net loss widens, hurt by clinical development costs
Brief: Cereno Scientific Q2 Loss After Financial Items SEK 30.5 Mln